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Cathelicidin peptides play key roles in host responses to infection. Radek and colleagues (2010) demonstrate
that the nicotinic acetylcholine system, activated during stress, suppresses production of mouse cathelici-
din, increasing host susceptibility to the pathogen Staphylococcus aureus. This suggests a distinct way
by which the endocrine system regulates innate immunity.Homeostasis is the ability of an organism
to regulate its internal environment so as
to maintain a relatively constant state
that permits cells to function normally in
the face of external and internal perturba-
tions. The concept of homeostasis is
critical to understanding human biology
and physiology, and humans, like other
animals, utilize their (neuro)endocrine sys-
tem to regulate this process. The endo-
crine system consists of two central
‘‘command’’ organs, the hypothalamus
and pituitary, and a variety of distributed
effector organs, including the thyroid,
adrenal, and reproductive organs. The
hypothalamus and pituitary monitor input
from a variety of receptors that serve to
monitor the body’s internal milieu, inte-
grate this information with neuronal input
from the brain, and turn on or off the
effector organs in response to this input.
The analogy of a heating circuit is often
used to illustrate the basic principles
of the endocrine system. The system
consists of a ‘‘thermostat’’ (the hypothal-
amus) that establishes a specific phys-
iological ‘‘set point,’’ maintaining body
temperature at 37C. As body tempera-
ture fluctuates, it is monitored by the ther-
mostat for drift from the set point. When
the temperature drifts too far, heating or
cooling effector systems (under control
of the pituitary) become active and help
return the temperature to a value within
the acceptable range of drift from the set
point.
The endocrine system has a strong
neural component that, in humans, origi-
nates from a region of the brain called
the hypothalamus. The hypothalamusintegrates both neuronal input from the
brain and physiological input from
the body and uses this information to
establish set points through the pulsa-
tile release of regulatory hormones. For
example, pyrogenic molecules such as
IL-1b, IL-6, and bacterial lipopolysaccha-
ride (LPS) induce fever by acting directly
on neural cells in the hypothalamus,
reprogramming the temperature set point
to a higher value (Blatteis et al., 2000). The
pituitary gland receives input from the
hypothalamus regarding set point targets,
and it, in turn, decides which effector
organ to turn on in the event that a moni-
tored parameter has drifted significantly
from the set point. For example, ther-
moregulation can involve alterations in
thyroid stimulating hormone (TSH) secre-
tion, with the thyroid gland as an effector
system, whereas changes in stress state
use adrenocorticoid-releasing hormone
(ACTH) targeted to the adrenal gland,
which, in turn, alters production of stress
hormones, including catecholamines and
cortisol (an endogenous corticosteroid).
In addition to homeostasis, the endo-
crine system also regulates allostasis, or
the ability to re-establish homeostasis in
the face of external stressors (McEwen,
1998). Whereas homeostatic systems
are critical for life and must be maintained
within tight ranges, allostatic systems can
drift considerably from their set points
without harmful consequences, as long
as the drift is only temporary (McEwen
and Wingfield, 2003). Regulation of allo-
stasis originates from the endocrine
system, as well as through direct sympa-
thetic (catecholamine) and parasympa-Cell Host & Microbthetic (acetylcholine) nerve innervation of
key organs. Examples of homeostatic
systems include blood oxygenation, pH,
and body temperature, whereas allostatic
systems include heart rate, blood pres-
sure, metabolism, and salt retention. The
concept of the immune system as an
endocrine effector ‘‘organ’’ has recently
became a topic of discussion in the fields
of neurology, endocrinology, and immu-
nology (Rosas-Ballina and Tracey, 2009;
Oke and Tracey, 2008; Brogden et al.,
2005). Susceptibility to infection has long
been known to be affected by the psycho-
logical and physiological ‘‘stress state’’ of
individuals, and susceptibility to chronic
autoimmune diseases shows a similar
correlation with stress state. In light of
these findings, and as further illustrated
in this issue of Cell Host & Microbe by
Radek et al. (2010), there is mounting
evidence that the innate immune system
is an effector organ regulating homeo-
stasis and allostasis by a classical endo-
crine regulatory mechanism (Figure 1A).
The paper by Radek et al. (2010) high-
lights a new player that integrates the
endocrine and immune systems, namely
small cationic host peptides termed vari-
ously ‘‘antimicrobial’’ or ‘‘host defense’’
peptides. They show that stimulation
through nicotinergic acetylcholine recep-
tors plays a role in downregulating tissue
levels of cathelicidin (and perhaps other
cationic host defense peptides). Catheli-
cidins, including mouse CRAMP, bovine
indolicidin, and human LL-37, are endog-
enous peptides with a broad range of
immunomodulatory and (under appro-
priate conditions) antimicrobial activitiese 7, April 22, 2010 ª2010 Elsevier Inc. 257
Figure 1. Interface between the Endocrine System and Innate Immunity
(A–D) The relationship between the endocrine system and innate immunity is presented within the framework of the allostasis model of stress response (McEwen
and Wingfield, 2003). The human body maintains homeostasis in the face of stressors by increasing allostatic load (A) until the acute stressor is no longer active or
significant and the system returns to baseline (B). The system adapts to chronic stressors by changing initial set points (So) to higher values (S1) (A, red pathways),
resulting in prolonged production of CRAMP and continuous activation of stress pathways (C). Alternatively, adaptation can occur by engaging anti-stress circuits
that utilize cortisol and ACh (A, green pathways), suppressing production of CRAMP and decreasing the allostatic load (D).
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onstrate that decreased CRAMP pro-
duction due to endocrine regulation cor-
relates with an increased susceptibility
to infection. This finding provides intrigu-
ing evidence that the enhanced suscepti-
bility to infection present in chronic stress
states might be due to dysregulated
cathelicidin production associated with
cholinergic system activity that is ulti-
mately maladaptive.
This work is a significant advancement
in understanding endocrine regulation of
innate immunity on multiple fronts. First,
whereas the endocrine system is known
to regulate the production of host defense
neuropeptides during infection (Brogden
et al., 2005), Radek et al. (2010) dem-
onstrate that CRAMP is regulated in a
similar manner, providing an important
interface between the endocrine and
immune systems. Second, Radek et al.258 Cell Host & Microbe 7, April 22, 2010 ª2raise the fascinating possibility that
pathogenic organisms such as Staphylo-
coccus aureus exploit these regulatory
systems in the process of causing dis-
ease. This possibility is consistent with
the known ability of S. aureus to evade
host defense peptides during human
infections (Kraus and Peschel, 2008).
When these findings are placed within
the larger framework of endocrine control
of immunity, acute stress, and subse-
quent allostatic drift (McEwen, 1998;
McEwen and Wingfield, 2003), a cohesive
model for the integration of these systems
becomes apparent. Stress insults to the
host induce increased allostatic load,
which is the physiological cost to the
organism of maintaining homeostasis
during stress (Figures 1A and 1B). The
initial allostatic response is achieved,
acutely, by the ‘‘fight or flight’’ hormones,
norepinephrine/epinephrine, and through010 Elsevier Inc.immediate production of cortisol, each
of which upregulate production of antimi-
crobial peptides in the skin. When the
stress resolves, the allostatic load disap-
pears and the system returns to its
homeostatic set point (Figure 1B).
In situations wherein stress to the
organism is nonresolving (i.e., chronic),
the host endocrine system selects an
appropriate response. One response
involves the acceptance of a continuing
elevation in allostatic load (Figure 1C),
either through desensitization or set point
modification, ultimately resulting in the
development of chronic disease states
(McEwen, 1998). In line with this form of
adaptation, enduring upregulation of the
production of LL-37 has been associated
with chronic dermatological inflammatory
diseases such as psoriasis (Lande et al.,
2007) and atopic dermatitis (Ong et al.,
2002). In a second type of response
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stress circuits that counterbalance allo-
static systems, e.g., the anti-inflammatory
cholinergic and glucocorticoid pathways.
Prolonged activation of these adaptive
systems ultimately becomes maladap-
tive, leading to immunosuppression and
increased susceptibility to infectious dis-
eases, a model that is further substanti-
ated here by Radek et al. (2010).
Significantly, this paper demonstrates
the specific means and receptor types
by which the cholinergic systems regulate
cathelicidin production in the skin. This
opens many new avenues for therapeutic
intervention in inflammatory and infec-
tious conditions triggered by states of
chronic stress. For example, overproduc-
tion of cathelicidins implicated in psori-
asis could be attenuated by the topical
application of a designer nicotinic agonist;
whereas, conversely, underproduction of
cathelicidins could be reversed by topical
applications of cathelicidins (or other hostpeptides) or by designer nicotinic antago-
nists as part of anti-infective strategies.
Clinical trials of known inducers of host
defense peptides (vitamin D and sodium
butyrate) in the context of infection are
already underway, and thus proof of prin-
ciple of this approach is already being
established. In the world of increasing
global resistance to conventional antimi-
crobial agents and increasing preva-
lence of auto-inflammatory conditions,
this type of ‘‘thinking outside the box’’
will become increasingly critical in the
prophylaxis and treatment of human
infectious and inflammatory diseases.REFERENCES
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As part of innate immune signaling, plants employ a suite of receptors, kinases, and resistance proteins
to recognize pathogen-derived effector proteins. In this issue of Cell Host & Microbe, Zhang et al. provide
evidence refining the link between multiple layers of defense signaling in response to bacterial pathogen
infection.Recent studies have highlighted the
molecular-genetic arms race between
the plant immune system and pathogen
virulence effectors (reviewed in Chisholm
et al., 2006 and Jones and Dangl, 2006).
In particular, pathogen effectors often
target the plant immune response net-
work (Boller and He, 2009), and in return,
plants refine and expand their immune
system to defend against pathogens. In
this issue of Cell Host & Microbe, Zhang
et al. (2010), present evidence that severalrelated Arabidopsis cytoplasmic receptor
kinases, exemplified by botrytis-induced
kinase 1 (BIK1) (Veronese et al., 2006)
and AvrPphB susceptible (PBS1) (Shao
et al., 2003), are cleaved by AvrPphB, a
cysteine protease effector from the phy-
topathogenic bacterium Pseudomonas
syringae. BIK1 turns out to be particularly
important for plant immune responses,
illustrating an excellent example of the
utility of pathogen effectors as molecular
probes in identifying new components ofthe plant immune system. This work also
provides new insights as to how plants
recognize the virulence action of AvrPphB
and use it against bacterial infection.
Innate immune signaling in plants is
initiated as a consequence of the recog-
nition of specific pathogen-associated
molecular patterns (PAMP) by cognate
plasma membrane-localized pathogen
recognition receptors (PRRs). Collectively
referred to as PAMP-triggered immunity
(PTI) (Chisholm et al., 2006; Jones ande 7, April 22, 2010 ª2010 Elsevier Inc. 259
